Kyntra Bio, Inc. · NASDAQ:KYNB
Wettig Thane had 209 Kyntra Bio, Inc. shares withheld for tax (Form 4)
Traded Sep 6, 2026 · Filed Sep 9, 2026
On Sep 6, 2026, Wettig Thane (Director, CEO) had 209 Kyntra Bio, Inc. shares withheld for tax at US$8.55 for US$1,787, leaving 26,796 shares. Filed Sep 9, 2026 (Form 4).
- Withheld for tax
- 209 shares
- Price
- US$8.55
- Value
- US$1,787
- Holding after
- 26,796 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 6, 2026 | Common Stock | Shares withheld for tax | 209 | US$8.55 | 26,796 | Direct |
Source
Related
- Kyntra Bio, Inc.
- Wettig Thane
- Kyntra Bio, Inc. shareholders
- Form 4 · Wettig Thane · Jun 9, 2026
- Form 4/A · Wettig Thane · May 19, 2026
- Form 4 · DeLucia David · Sep 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · DeLucia David · Jun 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · Feb 17, 2026